Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK

PURPOSE: Our objective was to estimate the economic outcomes of using mirabegron versus antimuscarinics in the treatment of patients with overactive bladder (OAB) from a societal perspective in the UK. MATERIALS AND METHODS: A Markov model was developed using Microsoft Excel(®). The time horizon and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmacoecon Open
Autors principals: Nazir, Jameel, Berling, Malin, McCrea, Charles, Fatoye, Francis, Bowditch, Sally, Hakimi, Zalmai, Wagg, Adrian
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2017
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5689035/
https://ncbi.nlm.nih.gov/pubmed/29442303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41669-017-0011-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars